Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
-1.72%
)
Bitcoin
70,292.00
(
-0.32%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: bridgeofsighs post# 79711

Friday, 05/21/2010 6:44:37 AM

Friday, May 21, 2010 6:44:37 AM

Post# of 257268
CHMP approves AGN’s Ozurdex biodegradable implant for macular edema:

http://www.reuters.com/article/idCNLDE64K0W820100521

Ozurdex was approved by the FDA for macular edema in Jun 2009 (#msg-38873404); AGN submitted an application for approval in posterior uveitis during 4Q09 (#msg-46265367).


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today